The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes - PubMed (original) (raw)
. 2007 May;30(5):1206-11.
doi: 10.2337/dc06-1484. Epub 2007 Jan 26.
Affiliations
- PMID: 17259472
- DOI: 10.2337/dc06-1484
The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes
Peter C Tong et al. Diabetes Care. 2007 May.
Abstract
Objective: The purpose of this study was to compare the predictive value for coronary heart disease (CHD) of the International Diabetes Federation (IDF) definition (with Asian criteria for central obesity) of the metabolic syndrome with existing criteria of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) in Chinese subjects with type 2 diabetes.
Research design and methods: Subjects with type 2 diabetes and without macrovascular diseases or end-stage renal disease were categorized by the criteria of the IDF and the NCEP ATP III. CHD was defined as myocardial infarction, ischemic heart disease, coronary revascularization, heart failure, and death related to CHD.
Results: Of 4,350 patients (aged 54.4 +/- 13.4 years; median follow-up period 7.1 [interquartile range 5.2-8.5] years), 65.9% had metabolic syndrome according to either IDF or NCEP ATP III criteria. The NCEP ATP III definition identified metabolic syndrome in 786 subjects (18.1%) who did not fulfill the criteria of the IDF. HDL cholesterol and systolic blood pressure were predictors of CHD after adjustment for other confounding factors. Compared with subjects without metabolic syndrome, the IDF criteria failed to predict CHD (hazard ratio 1.13 [95% CI 0.86-1.48], P = 0.374). In contrast, the NCEP ATP III definition (2.51 [1.80-3.50], P < 0.001) predicted an increased risk of CHD with the NCEP-only group having the highest risk (2.49 [1.66-3.73], P < 0.001).
Conclusions: With established type 2 diabetes, the IDF definition of the metabolic syndrome failed to identify a subgroup of patients who had the highest risk for CHD. Practitioners must recognize the appropriate setting for its application.
Similar articles
- The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO, Ma RC, So WY, Yang XL, Kong AP, Ozaki R, Ko GT, Chow CC, Cockram CS, Chan JC, Tong PC. Luk AO, et al. Diabet Med. 2008 Dec;25(12):1419-25. doi: 10.1111/j.1464-5491.2008.02602.x. Diabet Med. 2008. PMID: 19046240 - Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E, Huzmeli C, Guven O, Savas N, Gullu M, Asilyoruk S, Kuvandik C, Temizkan A, Kuvandik G. Ucar E, et al. Ren Fail. 2009;31(3):221-8. doi: 10.1080/08860220802669883. Ren Fail. 2009. PMID: 19288328 - Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW. Meigs JB, et al. Diabetes Care. 2007 May;30(5):1219-25. doi: 10.2337/dc06-2484. Epub 2007 Jan 26. Diabetes Care. 2007. PMID: 17259468 - New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
Talbert RL. Talbert RL. Am J Manag Care. 2002 Sep;8(12 Suppl):S301-7. Am J Manag Care. 2002. PMID: 12240701 Review. - Epidemiology of metabolic syndrome in Asia.
Pan WH, Yeh WT, Weng LC. Pan WH, et al. Asia Pac J Clin Nutr. 2008;17 Suppl 1:37-42. Asia Pac J Clin Nutr. 2008. PMID: 18296297 Review.
Cited by
- Association of Dietary Patterns with Cardiovascular Disease Risk Factors in Mexican Adults: Insights from a Cross-Sectional Descriptive Study.
Vázquez-Aguilar A, Rueda-Robles A, Rivas-García L, Vázquez-Lorente H, Duque-Soto CM, Jiménez-López KL, Marín-Arriola IC, Sánchez-Jiménez MA, López-Uriarte PJ. Vázquez-Aguilar A, et al. Nutrients. 2024 Mar 12;16(6):804. doi: 10.3390/nu16060804. Nutrients. 2024. PMID: 38542715 Free PMC article. - Does metabolic syndrome increase the risk of fracture? A systematic review and meta-analysis.
Babagoli M, Soleimani M, Baghdadi S, Vatan MS, Shafiei SH. Babagoli M, et al. Arch Osteoporos. 2022 Aug 31;17(1):118. doi: 10.1007/s11657-022-01149-y. Arch Osteoporos. 2022. PMID: 36042109 Review. - Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer.
Geng JH, Plym A, Penney KL, Pomerantz M, Mucci LA, Kibel AS. Geng JH, et al. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):320-326. doi: 10.1038/s41391-022-00494-w. Epub 2022 Jan 24. Prostate Cancer Prostatic Dis. 2022. PMID: 35075214 - The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17.
Yang GR, Yuan MX, Fu HJ, Wan G, Li D, Dye TD, Zhu LX, Xie RR, Lv YJ, Zhang JD, Du XP, Li YL, Ji Y, Li Y, Cui XL, Wang ZM, Cheng SY, Liu DY, Wang Q, Zhou L, Gao Y, Yuan SY. Yang GR, et al. J Diabetes Res. 2019 Jun 12;2019:5237371. doi: 10.1155/2019/5237371. eCollection 2019. J Diabetes Res. 2019. PMID: 31281851 Free PMC article. - Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis.
Hallajzadeh J, Khoramdad M, Karamzad N, Almasi-Hashiani A, Janati A, Ayubi E, Pakzad R, Sullman MJM, Safiri S. Hallajzadeh J, et al. J Cardiovasc Thorac Res. 2018;10(2):56-69. doi: 10.15171/jcvtr.2018.10. Epub 2018 May 28. J Cardiovasc Thorac Res. 2018. PMID: 30116503 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical